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Abstract
Background: Many low- and middle-income countries are not on track to reach the public health targets set out in the
Millennium Development Goals (MDGs). We evaluated whether differential progress towards health MDGs was associated
with economic development, public health funding (both overall and as percentage of available domestic funds), or health
system infrastructure. We also examined the impact of joint epidemics of HIV/AIDS and noncommunicable diseases (NCDs),
which may limit the ability of households to address child mortality and increase risks of infectious diseases.
Methods and Findings: We calculated each country’s distance from its MDG goals for HIV/AIDS, tuberculosis, and infant and
child mortality targets for the year 2005 using the United Nations MDG database for 227 countries from 1990 to the present.
We studied the association of economic development (gross domestic product [GDP] per capita in purchasing-power-
parity), the relative priority placed on health (health spending as a percentage of GDP), real health spending (health system
expenditures in purchasing-power-parity), HIV/AIDS burden (prevalence rates among ages 15–49 y), and NCD burden (age-
standardised chronic disease mortality rates), with measures of distance from attainment of health MDGs. To avoid spurious
correlations that may exist simply because countries with high disease burdens would be expected to have low MDG
progress, and to adjust for potential confounding arising from differences in countries’ initial disease burdens, we analysed
the variations in rates of change in MDG progress versus expected rates for each country. While economic development,
health priority, health spending, and health infrastructure did not explain more than one-fifth of the differences in progress
to health MDGs among countries, burdens of HIV and NCDs explained more than half of between-country inequalities in
child mortality progress (R
2-infant mortality =0.57, R
2-under 5 mortality =0.54). HIV/AIDS and NCD burdens were also the
strongest correlates of unequal progress towards tuberculosis goals (R
2=0.57), with NCDs having an effect independent of
HIV/AIDS, consistent with micro-level studies of the influence of tobacco and diabetes on tuberculosis risks. Even after
correcting for health system variables, initial child mortality, and tuberculosis diseases, we found that lower burdens of HIV/
AIDS and NCDs were associated with much greater progress towards attainment of child mortality and tuberculosis MDGs
than were gains in GDP. An estimated 1% lower HIV prevalence or 10% lower mortality rate from NCDs would have a similar
impact on progress towards the tuberculosis MDG as an 80% or greater rise in GDP, corresponding to at least a decade of
economic growth in low-income countries.
Conclusions: Unequal progress in health MDGs in low-income countries appears significantly related to burdens of HIV and
NCDs in a population, after correcting for potentially confounding socioeconomic, disease burden, political, and health
system variables. The common separation between NCDs, child mortality, and infectious syndromes among development
programs may obscure interrelationships of illness affecting those living in poor households—whether economic (e.g., as
money spent on tobacco is lost from child health expenditures) or biological (e.g., as diabetes or HIV enhance the risk of
tuberculosis).
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Remarkable efforts have been made towards meeting the health
MDGs over the past 8 years (Box 1), yet many of the poorest
countries are falling behind. As noted in the Report of the
Secretariat to the World Health Assembly, ‘‘At the mid-point in the
countdown to 2015, the target date set by the United Nations
Millennium Declaration, there are several examples of success.
However, great inequalities still exist within and between countries,
and current trends suggest that many low-income countries will not
reach the Millennium Development Goal targets’’ [1].
What explains these inequalities in progress toward the health
MDGs [2]? Slow progress in low-income countries cannot simply
be explained by their public health MDG targets being more
challenging. Reducing child mortality by two-thirds (MDG 4.1) or
maternal mortality by three-quarters (MDG 5.1) may be more
difficult when death rates are already low, as in rich countries.
One possibility is that countries simply lack the financial resources
needed to combat epidemics (i.e., low gross domestic product
[GDP] per capita). Even when funds are available, they may be
allocated to other forms of social spending, military expenditure,
or reserves, rather than to health (i.e., low health spending for each
dollar of GDP). A third possibility is that when funds enter the
health system, inadequate health infrastructure—such as a lack of
doctors, pharmaceuticals, or hospitals—prevent these allocations
from reaching those who need them most (i.e., low absorptive
capacity for spending).
However, another contributing factor could be coexisting
epidemics. For example, the spread of HIV has slowed progress
towards achievement of the tuberculosis goals by directly
increasing the risk of active tuberculosis disease and subsequent
death [3]. There are also multiple pathways by which higher adult
HIV prevalence might increase child mortality (beyond the
obvious mother to child transmission), estimated to account for a
significant fraction of deaths in sub-Saharan Africa [4]. These
include direct effects on the welfare of children (reduced earning
capacity of parents, cost of treatment, impoverishment of orphans)
and indirect mechanisms involving depletion of resources (illness
and death of health workers and teachers, diversion of resources
from child health care) [5–7].
In recent years,attentionhasturned tothecontributions made by
long-term noncommunicable conditions to the overall burden of
disease in poor countries [8]. These include cardiovascular
disorders, chronic obstructive pulmonary disease, diabetes, and
common cancers as well as disabling mental illness and injuries. It is
increasingly clear that the greatest burden of NCDs is among the
poor [9–13]. Their plight is not simply an inevitable consequence of
aging, as is sometimes argued [14]. Instead, traditional diets are
giving way to cheaper, unhealthy alternatives (the so-called
‘‘nutrition transition’’) [15], transnational tobacco companies
aggressively market their products in the developing world, and
urbanization and associated changes in employment have reduced
physical activity [16–18]. Crucially, in the present context, the
nature of the transition means that many families face a double
Box 1. Health Millennium Development Goals, Targets, and Indicators
In 2001, 192 United Nations member states agreed upon
three Millennium Development Goals (MDGs) to reduce child
mortality rates by two-thirds (MDG #4), maternal mortality
ratios by three-quarters (MDG #5), and halt and reverse the
spread of HIV, tuberculosis, and malaria by 2015 (MDG #6).
Note: Health outcome indicators available for study on a
longitudinal basis are italicised.
Goal 4: Reduce child mortality
N Target 4.A: Reduce by two-thirds, between 1990 and 2015,
the under-five mortality rate
# 4.1 Under-five mortality rate
# 4.2 Infant mortality rate
# 4.3 Proportion of 1 year-old children immunised against
measles
Goal 5: Improve maternal health
N Target 5.A: Reduce by three quarters, between 1990 and
2015, the maternal mortality ratio
# 5.1 Maternal mortality ratio
# 5.2 Proportion of births attended by skilled health personnel
N Target 5.B: Achieve, by 2015, universal access to repro-
ductive health
# 5.1 Contraceptive prevalence rate
# 5.2 Adolescent birth rate
# 5.3 Antenatal care coverage (at least one visit and at
least four visits)
# 5.4 Unmet need for family planning
Goal 6: Combat HIV/AIDS, malaria and other diseases
N Target 6.A: Have halted by 2015 and begun to reverse the
spread of HIV/AIDS
# 6.1 HIV prevalence among population aged 15–24 years
# 6.2 Condom use at last high-risk sex
# 6.3 Proportion of population aged 15–24 years with
comprehensive correct knowledge of HIV/AIDS
# 6.4 Ratio of school attendance of orphans to school
attendance of non-orphans aged 10–14 years
N Target 6.B: Achieve, by 2010, universal access to treatment
for HIV/AIDS for all those who need it
# 6 . 5P r o p o r t i o no fp o p u l a t i o nw i t ha d v a n c e dH I V
infection with access to antiretroviral drugs
N Target 6.C: Have halted by 2015 and begun to reverse the
incidence of malaria and other major diseases
# 6.6 Incidence and death rates associated with malaria
# 6.7 Proportion of children under 5 sleeping under
insecticide-treated bed nets
# 6.8 Proportion of children under 5 with fever who are
treated with appropriate anti-malarial drugs
# 6.9 Incidence, prevalence and death rates associated with
tuberculosis
# 6.10 Proportion of tuberculosis cases detected and cured
under directly observed treatment short course
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and poverty [19]. For example, 44% of families with an
undernourished member in Brazil also had an overweight member,
with high prevalence also observed in China (23%) and Russia
(58%) [20]. A survey of very-low-income populations in Maceio,
Brazil found that 30% of all families had both an underweight and
overweight–obese member living under the same roof [21].
As with HIV/AIDS, NCDs and their risk factors can impact
adversely on attainment of the health MDGs (Table 1). In some cases
this is due to the biological consequences of NCDs and their risk
factors.Forexample, in the case of tuberculosis, WHO notes that ‘‘Risk
factors that seem to be of importance at the population level include
poor living and working conditions associated with high risk of TB
transmission, and factors that impair the host’s defence against TB
infection and disease, such as HIV infection, malnutrition, smoking,
diabetes, alcohol abuse, and indoor air pollution.’’ (emphases added) [22].
Although the increased relative risk of tuberculosis associated with
smoking and diabetes is less than for HIV infection, in some
populations the higher prevalence of these factors leads to a greater
population attributable risk. A recent study by Dye and colleagues in
India estimated that diabetes accounts for 20% of smear-positive
tuberculosis incidence, with the higher prevalence of diabetes in urban
areas explaining one-fifth of the gap in smear-positive disease between
urban and rural areas [23]; other studies in Latin America have
attributed as much as one-quarter of pulmonary tuberculosis incidence
to diabetes and, in India, over half of tuberculosis mortality to tobacco
[11,24,25]. Among children, exposure to second-hand tobacco smoke
and smoke-producing stoves increases risks of respiratory infections
(one of the leading causes of death in the very poorest children) and
sudden infant death.
However, expenditures on the risk factors for NCDs and the
management of these disorders can also impact adversely on the
financial well-being of families, placing them at risk in relation to
the conditions included in the health MDGs. Thus, tobacco
expenditures in Bangladesh have exceeded spending on health,
education, and clothing by a factor of five [26]; this spending was
found to have been displaced from nutrition and health care,
where it would have added as much as 500 calories per day to the
diets of otherwise potentially undernourished children [27].
Treatment for diabetes costs 15%–25% of incomes in households
with an affected person in India [28], 25% of the minimum
wage (20 times the per capita health expenditure) in Tanzania
[29], 6–12 months’ wages (US$160 per year) in Bangladesh [30],
and roughly US$550 per person in Latin America (more than
average per capita health expenditure) [31], while health care for
smoking-related diseases accounts for 0.48% of GDP in Thailand
[32]. Research from countries as diverse as Burkina Faso [33] and
Thailand [34] find that the presence of a chronic illness in a family
is one of the most important determinants of whether the
household will incur catastrophic health expenditure.
New insights on the importance of NCDs are being obtained
from longitudinal studies that track health expenditure in families,
rather than previous facility-based studies of utilization. Thus, in
South Africa a household survey found that 74% of reported health
problems were ‘‘chronic,’’ 48% of which had received no treatment
in the previous month. In a linked follow-up of households, among
subjects with chronic illness, only 62% had an allopathic diagnosis
and only 35% were receiving regular treatment [35]. A study in
India found that chronic diseases represented 17.7% of illnesses but
32% of costs. Although hospitalizations were the single most costly
component on average, they accounted for only 11% of total costs,
compared to drugs, accounting for 49% of total costs [36].
Finally, the onset of an NCD also appears to restrict earning
potential [37–41] and undermine a family’s ability to provide for
children. High background rates of chronic NCD morbidity and
mortality among adults results in losses of adult care providers, and
disability among adults prevents efforts to secure child health, or to
obtain diagnoses and complete treatment for infectious diseases.
Table 1 further summarises the evidence of how high burdens of
NCDs impede progress to health MDGs.
In this paper, we compare several of the leading explanations of slow
progress towards health MDGs, including the effects of low economic
development, a lack of health prioritisation by governments, low
absolute health spending, and scarce health infrastructure. While some
recent studies identify barriers to achieving progress towards MDGs in
individual countries or regions (especially sub-Saharan Africa) or for
individual diseases [42,43], there remains a need to test the
relationships across health MDGs and low-, middle-, and high-income
countries. For what we believe is the first time, we also test the
hypothesis that coexisting epidemics of HIV/AIDS and NCDs impede
progress towards the health MDGs, after controlling for the potential
economic and health system barriers to achieving the health MDGs.
Data and Methods
We extracted data on MDG indicators from the United Nations
Millennium Development Goal Indicator Database 2009 edition
for 227 countries spanning 1990 to 2008 [44]. Complete time
series data related to some health MDGs in low income countries
were missing from the UN repository (Text S1). This was a
Table 1. Selected Effects of NCDs and injuries and their risk factors on health MDGs.
Health MDG Type of Pathway Effect of NCD and NCD risk factors on health MDG
MDG #4. Reduce Child Mortality Biological Tobacco increases probability of low birthweight [61,64]
Social Alcohol, tobacco and out-of-pocket long-term chronic disease care household expenditures
displace spending on nutrition (up to 500 calories per child per day) [26,28,65]
MDG #5. Improve Maternal Health Biological Tobacco, obesity and diabetes create high-risk childbirth conditions [66]
MDG #6. Combat HIV/AIDS, malaria and
other diseases [including tuberculosis]
Biological Tobacco increases risk of tuberculosis by about 2-fold [11,25]
Biological Diabetes increases risk of tuberculosis and MDR by about 3-fold; estimated to be
attributable for 10% of TB in India and China and 15% globally [23,67]
Biological Tobacco increase risks for HIV infection [Furber AS, Maheswaran R, Newell JN, Carroll C
(2007) Is smoking tobacco an independent risk factor for HIV infection and progression to
AIDS? A systemic review. Sex Transm Infect 83: 41-46.]
Notes: See Text S6 for more details.
doi:10.1371/journal.pmed.1000241.t001
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the information on maternal mortality in low-income countries
derives from the sisterhood method, which is designed to yield a
lifetime risk [45] and, while data on the prevalence of malaria are
now much more widely available, historical data are very limited
[46]. Hence we limited the analysis to the indicators available for
evaluating rates of progress toward the MDG target, which
corresponded to child health, tuberculosis, and HIV. Fortunately,
these are also the health MDGs where we hypothesise that an
association with NCD burden might be expected. In Box 1, we
highlight the MDG indicators used in the assessment.
We calculated the change in the appropriate variable that would
be required by 2005 to place each country on target to achieve
each MDG. For example, MDG 4, which aims ‘‘to reduce infant
and child mortality by two-thirds by 2015,’’ would require a 40%
reduction in infant and child mortality rates by 2005 assuming a
uniform (linear) rate of progress. We note that this linear
transformation of the outcome variable is statistically equivalent
to an alternative approach of first modelling the real values, then
offsetting by the baseline mortality data; however, to ensure
consistency with our hypothesis, we present the transformed
results. The health MDG targets are set out at http://www.un.
org/millenniumgoals/.
To measure ‘‘unmet MDG progress,’’ we then divided the actual
change in the variable achieved by 2005 by the target for that year:
Unmet MDG Progress % ðÞ ~100| 1{
Actual DMR
MDG Target DMR
 
ð1Þ
Using the above example, the resulting value would be 25% for
a country achieving a 30% reduction in infant and child mortality
rates (1006[(12(30/40)]) or, put more simply, would be 25%
adrift from where it should be by 2005. Countries which exceeded
the MDG target were coded as negative unmet progress (although
the results were unchanged when the score was truncated at zero
unmet progress). For countries which moved in reverse, or
experienced rises in mortality rates (e.g. a total of 13 countries
for infant mortality), it was possible to have greater than 100%
unmet MDG progress.
Data on MDG 5, ‘‘to reduce maternal mortality by two-thirds,’’
were available only on a comparative basis for 2005. MDG 6, ‘‘to
halt and reverse the incidence, prevalence and mortality of HIV,
malaria and other diseases [including tuberculosis],’’ was coded as
a dichotomous variable. Countries which experienced rises in
tuberculosis mortality and HIV prevalence rates were assigned the
value 1, denoting unmet progress, whereas those which had no
change or reduction were assigned 0. This enabled comparisons of
progress in both MDG 4 and 6 based on the probability of (or the
percentage of) MDG success.
We used the World Bank’s methods [47] to designate countries
as low-, middle-, and high-income, based not on their yearly GDP
per capita but on their average GDP per capita from 1990 to
2005. This avoids classifying countries with successful growth
strategies as higher-income, or poor economic performers as
lower-income, which could potentially bias a statistical analysis of
mortality changes among them.
To study the determinants of progress to the MDGs, we
modelled the MDG indicators as:
Unmet MDG Progressi~azb1GDPizb2HGDPizb3HSi
zb4PHYizb5HIVizb6NCDi
ð2Þ
where i is country. GDP is GDP per capita in purchasing-power-
parity from the Penn World Tables version 6.2 for the year 2003
(because there were data for 92 additional countries in this version
of the tables than in more recent editions); HGDP is health
spending as a percentage of GDP from the WHO Statistical
Information Database for the year 2005; HS is health spending per
capita in purchasing-power-parity and PHY is the number of
physicians per 10,000 population, both from the WHO Statistical
Information Database for the year 2005 [48]; HIV is HIV
prevalence among ages 15–49 y, the HIV indicator available from
the UN MDG database for the years 2006/2007; and NCD is the
WHO Global Burden of Disease estimates of NCD mortality rates
for the year 2004 (the most recent year available from WHO [49];
this includes WHO classification scheme Group 2 causes, age-
standardised to the WHO World Standard Population to adjust
for potential errors arising from differences in the population age-
structure [50], given that NCDs contribute a greater share of
deaths at older ages) [48]. Log transformations were applied to
GDP and NCD data to adjust for positive skew and aid model
fitting. Note that we analysed the variance in the rates of change in
MDG progress relative to baseline rates of change, correcting for
spurious correlations that may exist simply because countries with
high disease burdens would be expected to have low MDG
progress. We specifically controlled for the initial burden of disease
estimates and rates of change in those estimates among countries
when performing our regressions by incorporating expected
mortality rates in the calculation of unmet MDG progress.
Huber/White sandwich estimators of standard errors are
presented for consistency in the presence of potential hetero-
skedasticity. To facilitate the interpretation of the models, we have
transformed estimated coefficients into elasticities and interpreted
the effect sizes based on units to improve clarity and compara-
bility. Data were analysed using STATA 10.1. All data are
available upon request from the authors.
Results
Inequalities in Progress to Health MDGs
Figure 1 compares progress toward health MDGs among low-,
middle-, and high-income countries and by World Bank region.
Out of 71 low-income countries for which data are available,
rising death rates have been recorded in 37 countries for
tuberculosis since 1990 (MDG 6.9); in seven and nine countries
for infant and child mortality rates, respectively, since 1990
(MDG 4.1 and 4.2); and in 17 countries for HIV prevalence
(MDG 6.1) from 2001 to 2007 (the period for which data are
available). Compared to high- and middle-income countries, low-
income countries are about one-quarter less likely to be on pace
to reach the HIV and TB targets set out in MDG 6 (23.7%, 95%
CI 7.8%–39.4%) and the child mortality targets in MDG 4
(27.6%, 95% CI 10.5%–44.7%).
As shown in Figure 2, sub-Saharan Africa had the slowest
progress (82.1% unmet progress in child mortality, 79.5% in
tuberculosis mortality, and 31.7% in HIV prevalence), followed
by Europe and Central Asia (2.4% unmet progress in child
mortality, 76.2% in tuberculosis mortality, and 40.0% in HIV
prevalence).
At current rates of progress, fewer than half of low-income
countries will achieve the 2015 targets set for HIV prevalence or
infant, child, and tuberculosis mortality rates. Inequalities between
the global north and south have been rising, as progress towards
MDGs has not only been much slower in the south, but has moved
into reverse for a substantial number of the lowest-income
countries, as indicated by the .100% unmet progress (Text S2).
ð1Þ
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We now examine each of the possible explanations for
inequalities in progress towards the MDGs postulated earlier.
The first possibility is that poor countries simply lack the
financial resources to tackle their public health goals. Table 2
shows the results of a statistical model relating the level of earnings
(GDP per capita in purchasing-power-parity) to unmet MDG
progress. The model reveals that scaling up current forms of
economic development is not sufficient for success [11]. Each 10%
higher GDP per capita was associated with 1.80% greater progress
towards the infant mortality targets (95% CI 1.25%–2.35%),
1.64% greater progress towards the under-5 mortality target (95%
CI 1.05%–2.24%), and 1.64% greater progress toward the
tuberculosis mortality targets (95% CI 1.13%–2.14%). However,
less than one-sixth of unmet progress in combating infant, child,
and tuberculosis mortality, and almost none of progress in
combating HIV, could be attributed to differences in economic
development in this regression analysis (see also Text S2 for
representative values).
Another possibility is that overall financial resources are
theoretically sufficient but not being used to strengthen health
systems. We next included health spending as a percentage of
GDP as a measure of governmental priority given to health. While
each 1% higher health spending as a percentage of GDP was
associated with faster progress to the MDGs, the effects were not
statistically significant except for declines in HIV prevalence (each
percentage increase in spending/GDP changes HIV prevalence by
24.50% (95% CI28.39% to20.61%) (Table 3).
But perhaps financial resources or the proportion of these
resources apportioned to health are not as relevant as the absolute
number of dollars devoted to health per capita or the physical
capacity in the health care system. Hence, we next evaluated
the effects of real health spending and physicians per capita on
health MDG progress. We found no effect of greater health
spending (Table 4), but when we added physicians per capita
to the model (Table 5) we found that each 1 additional doctor per
10,000 population was strongly associated with greater progress
towards reducing progress toward infant mortality targets (1.43%,
95% CI 0.38%–2.49%) and under-5 mortality rates (1.44%,
0.31%–2.57%). After including physicians per capita in the model,
GDP per capita also no longer had a significant association with
progress on child mortality (p=0.3721), which is consistent with
a potential pathway linking GDP to greater human capital and
subsequent greater progress towards the MDGs. However, we
found that greater numbers of physicians per capita was associated
with slower progress in tuberculosis mortality rates (20.98%,
95% CI20.24% to 21.73%), which could indicate bias due to
better surveillance or, possibly, the contribution of poorly
regulated health care provision to the emergence of drug
resistance [51,52]. The full model—including real GDP per
capita, health as a percentage of GDP, real health spending
per capita, and physicians per capita—explained roughly one-fifth
of country inequalities, which leaves a sizable residual to be
accounted for.
Figure 1. Unmet progress towards Millennium Development Goals, by income group. Notes: Authors’ calculations. Unmet MDG Progress
is calculated in percentage terms as 100 * [1–(Actual DMR/Expected DMR)], for years 1990 and 2005 for infant, child, and tuberculosis mortality; 2001
and 2007 for HIV prevalence. Scores include negative values (i.e., greater than 100% progress). Source of data: Millennium Development Goals
Indicators, available at http://mdgs.un.org/unsd/mdg/Default.aspx. MDG #4 aims to reduce infant and child mortality by two-thirds by 2015. MDG
#6 aims to halt and reverse the incidence, prevalence and mortality of HIV, malaria and other diseases, including tuberculosis. Box 1 further defines
MDG targets. Income groups categorized based on the World Bank Atlas method based on their average GDP per capita from 1990 to 2005. For Box
plots see Text S8
doi:10.1371/journal.pmed.1000241.g001
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We next evaluated whether coexisting epidemics, specifically
high burdens of HIV/AIDS or NCDs accompanying high
burdens of child disease and tuberculosis, could be contributing
to the MDG inequalities observed. Coexisting epidemics can
create a ‘‘health trap.’’ That is, failure to control one disease
impedes progress on the other and (possibly) vice-versa; this could
occur both because of biological risks from comorbidities, and
because additional household spending or loss of income resulting
from one disease can deplete resources needed to combat threats
to child health (e.g., ability to pay for medical care for sick
children) [53] or comorbid infectious diseases (e.g., paying for
transportation to refill antituberculosis medication) [54].
First, we evaluated the relationship between tuberculosis and
child health MDGs and HIV prevalence among ages 15–49 y.
Table 6 shows that a high background rate of HIV prevalence
explains a much higher share of the inequalities between countries
in health MDG progress than the other economic and health
system variables. Each 1% higher HIV prevalence rate was
associated with 8.46% lower progress in infant mortality (95% CI
5.57%–11.41%) and 9.25% lower progress in under-5 mortality
(95% CI, 5.97%–12.5%). After adjusting for HIV prevalence,
more physicians per capita had no effect on progress towards child
mortality goals.
In Table 7 we included the age-standardised mortality rates
from NCDs. Over and above the previous correlates of health
MDG progress, we found each 10% greater NCD burden, which
corresponded roughly to one standard deviation in the global
country sample and has been proposed as a feasible target by
WHO [55], was associated with a 6.32% reduction in progress
toward infant mortality targets (95% CI 2.03%–10.6%) and a
Figure 2. Unmet progress towards Millennium Development Goals, by geographic region. Notes: Authors’ calculations. Unmet MDG Progress
is calculated in percentage terms as 100 * [1–(Actual DMR/Expected DMR)], for years 1990 and 2005 for infant, child, and tuberculosis mortality; 2001 and
2007 for HIV prevalence. Scores include negative values (i.e., greater than 100% progress). Source of data: Millennium Development Goals Indicators,
available at http://mdgs.un.org/unsd/mdg/Default.aspx. MDG #4 aims to reduce infant and child mortality by two-thirds by 2015. MDG #6a i m st oh a l t
and reverse the incidence, prevalence and mortality of HIV, malaria and other diseases, including tuberculosis. Box 1 further defines MDG targets. Zero
percent denotes complete progress. Geographic classification based on World Bank geographic categories for the year 2009: http://web.worldbank.org/
WBSITE/EXTERNAL/DATASTATISTICS/0,,contentMDK:20420458,menuPK:64133156,pagePK:64133150,piPK:64133175,theSitePK:239419,00.html
doi:10.1371/journal.pmed.1000241.g002
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(95% CI 1.03%–10.5%). Our full model (Equation 2, above)
depicted in Table 7 explained 56% of variation in country
progress in infant mortality and 53% of variation in under-5
mortality.
To put these associations into perspective, we found that the
association between a 1% lower HIV prevalence or 10% lower
NCD mortality and progress towards child mortality MDGs was
of magnitude similar to a 40% rise in GDP (corresponding to at
least 5 years of economic growth in low-income countries) (see
Text S9 for further decomposition analysis).
Associations of HIV and NCDs with Infectious Disease
Progress (MDG #6)
Tables 6 and 7 also present the associations of HIV and NCD
burdens with progress on tuberculosis and HIV MDGs. Each 1%
higher HIV prevalence was associated with a 5.35% lower rate of
progress on tuberculosis mortality (95% CI 26.62% to 24.08%).
Each 10% higher NCD mortality was associated with a 7.56%
reduction in progress toward tuberculosis mortality targets
(95% CI 24.73% to 10.4%). These estimates were similar in
magnitude to estimates of the population-attributable tuberculosis
risk from tobacco and diabetes by Dye and colleagues at WHO
[7]. We found no effect of NCDs on HIV prevalence, which
would be expected because the chronic NCDs increase risks of
death for persons living with HIV and, as a result, would exert
a downward effect on prevalence. Including chronic NCDs
also improved the fit of the models, such that our full model
explained 57% of variation in tuberculosis mortality among
countries. Consistent with the expectation that NCDs would not
further explain HIV inequalities, the model (including rates of
NCDs, baseline HIV prevalence, measures of economic devel-
opment, health prioritisation, health spending, and health
infrastructure) was only able to account for 5% of variations in
HIV prevalence.
The association of a 1% lower HIV prevalence or 10% lower
NCD burden with progress towards the tuberculosis MDG was of
a similar magnitude as a 80% rise in GDP.
Robustness Checks
We performed a series of robustness checks on both our data
and model specification, as set out in Text S2–S9. This included
Table 2. Associations of GDP per capita with percentage of unmet progress towards health-related MDGs.
Covariate Quantity of Unmet MDG Progress
Infant Mortality Rates Child Mortality Rates Tuberculosis Mortality Rates HIV Prevalence
10% higher GDP per capita 21.80%
***
[22.35 to 21.25]
21.64%
***
[22.24 to 21.05]
21.64%
***
[22.14 to 21.13]
0.039%
[20.62 to 0.70]
Number of countries 164 164 166 132
R
2 0.130 0.098 0.168 ,0.001
Notes: Results presented from four separate regression models. Constant estimated but not reported. 95% confidence intervals based on heteroskedasticity robust
standard errors in parentheses. Unmet MDG Progress is calculated in percentage terms as 1006[12(Actual DMR/Expected DMR)]. Multiplying each coefficient by 40%
transforms the coefficient to describe the associations with the percentage change in each outcome. Progress towards reducing infant mortality rates and child
mortality rates reflects MDG 4.1 and 4.2 and modelled using a linear standard regression model. Progress towards halting or reversing tuberculosis mortality rates
reflects MDG 6.9, and modelled using a linear probability model. Progress towards halting or reversing HIV prevalence reflects MDG 6.1, and modelled using a linear
probability model. Data are from UN Millennium Development Goals Indicators 2008 edition.
*p,0.05.
**p,0.01.
***p,0.001.
doi:10.1371/journal.pmed.1000241.t002
Table 3. Associations of GDP per capita and health spending/GDP with percentage of unmet progress towards health-related
MDGs.
Covariate Quantity of Unmet MDG Progress
Infant Mortality Rates Child Mortality Rates Tuberculosis Mortality Rates HIV Prevalence
10% higher GDP per capita 21.76%
***
[22.42 to 21.11]
21.63%
***
[22.33 to 20.93]
21.66%
***
[22.23 to 21.08]
0.43%
[20.32 to 1.18]
Health Spending as percentage of GDP 20.67%
[24.49 to 3.15]
20.41%
[24.48 to 3.67]
20.45%
[23.15 to 2.26]
24.50%
*
[28.39 to 20.61]
Number of Countries 163 163 163 131
R
2 0.131 0.098 0.174 0.035
Notes: Results presented from four separate regression models. Constant estimated but not reported. 95% confidence intervals based on heteroskedasticity robust
standard errors in parentheses. Unmet MDG Progress is calculated in percentage terms as 1006[12(Actual DMR/Expected DMR)]. Multiplying each coefficient by 40%
transforms the coefficient to describe the associations with the percentage change in each outcome. Progress towards reducing infant mortality rates and child
mortality rates reflects MDG 4.1 and 4.2 and modelled using a linear standard regression model. Progress towards halting or reversing tuberculosis mortality rates
reflects MDG 6.9, and modelled using a linear probability model. Progress towards halting or reversing HIV prevalence reflects MDG 6.1, and modelled using a linear
probability model. Data are from UN Millennium Development Goals Indicators 2008 edition.
*p,0.05.
**p,0.01.
***p,0.001.
doi:10.1371/journal.pmed.1000241.t003
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hospital beds per capita, as well as using different transformations
of the predictor variables and differing samples (low HIV-
prevalence according to the WHO StopTB cutpoints and low
MDG progress countries), finding that the results were consistent
among the various models (Text S3). We also compared the
association among low-, middle-, and high-income countries; the
associations between NCDs and MDG progress were consistent at
all levels of income, but greatest in low-income countries where the
burden of NCDs is largest (Text S4). We had some inevitable
concerns about the quality of the data on adult mortality from
NCDs. Although the Global Burden of Disease study (http://
www.who.int/topics/global_burden_of_disease/en/), from which
these data were obtained, was an enormous advance over pre-
viously available data sources, many of the data from poor
countries are based on estimates derived from models that, in some
cases, include child mortality derived from surveys. It is possible
that this could introduce an element of circularity. We examined
this possibility first by including a control for the different ways of
estimating data on NCD mortality [56,57] as well as by excluding
the 42 countries in our sample that derived adult mortality from
child mortality. Neither approach changed our results qualitatively
Table 4. Associations of GDP per capita, health spending/GDP, and health spending with percentage of unmet progress toward
health MDGs.
Covariate Quantity of Unmet MDG Progress
Infant Mortality Rates Child Mortality Rates Tuberculosis Mortality Rates HIV Prevalence
10% higher GDP per capita 21.55%
**
[22.46 to 20.64]
21.41%
**
[22.37 to 20.45]
21.69%
***
[22.42 to 20.96]
0.78%
[20.22 to 1.78]
1% higher Health Spending as percentage
of GDP
0.11%
[24.68 to 4.89]
0.37%
[24.76 to 5.49]
20.56%
[23.91 to 2.78]
23.29%
[27.35 to 0.77]
$10 higher Health Spending per capita (PPP) 20.054%
[20.18 to 0.075]
20.054%
[20.19 to 0.079]
0.0082%
[20.083 to 0.099]
20.084%
[20.20 to 0.036]
Number of Countries 163 163 163 131
R
2 0.133 0.100 0.174 0.045
Notes: Results presented from four separate regression models. Constant estimated but not reported. 95% confidence intervals based on heteroskedasticity robust
standard errors in parentheses. Unmet MDG Progress is calculated in percentage terms as 1006[1–(Actual DMR/Expected DMR)]. Multiplying each coefficient by 40%
transforms the coefficient to describe the associations with the percentage change in each outcome. Progress towards reducing infant mortality rates and child
mortality rates reflects MDG 4.1 and 4.2 and modelled using a linear standard regression model. Progress towards halting or reversing tuberculosis mortality rates
reflects MDG 6.9, and modelled using a linear probability model. Progress towards halting or reversing HIV prevalence reflects MDG 6.1, and modelled using a linear
probability model. Data are from UN Millennium Development Goals Indicators 2008 edition.
*p,0.05.
**p,0.01.
***p,0.001.
doi:10.1371/journal.pmed.1000241.t004
Table 5. Associations of GDP per capita, health spending/GDP, health spending, and physicians per capita with percentage of
unmet progress toward health MDGs.
Covariate Quantity of Unmet MDG Progress
Infant Mortality Rates Child Mortality Rates Tuberculosis Mortality Rates HIV Prevalence
10% higher GDP per capita 20.60%
[21.93 to 0.73]
20.46%
[21.88 to 0.96]
22.32%
***
[23.17 to 21.48]
0.78%
[20.39 to 1.94]
1% higher Health Spending as percentage of GDP 1.92%
[23.52 to 7.37]
2.19%
[23.72 to 8.11]
21.84%
[25.48 to 1.80]
23.31%
[27.43 to 0.82]
$10 higher Health Spending per capita (PPP) 20.039%
[20.16 to 0.082]
20.039%
[20.17 to 0.090]
20.0037%
[20.095 to 0.088]
20.084%
[20.21 to 0.038]
1 additional physician/10,000 pop. 21.43%
**
[22.49 to 20.38]
21.44%
*
[22.57 to 20.31]
0.98%
**
[0.24 to 1.73]
0.0093%
[20.85 to 0.86]
Number of Countries 163 163 163 131
R
2 0.190 0.152 0.215 0.045
Notes: Results presented from four separate regression models. Constant estimated but not reported. 95% confidence intervals based on heteroskedasticity robust
standard errors in parentheses. Unmet MDG Progress is calculated in percentage terms as 1006[1–(Actual DMR/Expected DMR)]. Multiplying each coefficient by 40%
transforms the coefficient to describe the associations with the percentage change in each outcome. Progress towards reducing infant mortality rates and child
mortality rates reflects MDG 4.1 and 4.2 and modelled using a linear standard regression model. Progress towards halting or reversing tuberculosis mortality rates
reflects MDG 6.9, and modelled using a linear probability model. Progress towards halting or reversing HIV prevalence reflects MDG 6.1, and modelled using a linear
probability model. Data are from UN Millennium Development Goals Indicators 2008 edition.
*p,0.05.
**p,0.01.
***p,0.001.
doi:10.1371/journal.pmed.1000241.t005
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2(1)=3.60, p=0.0551
and x
2(1)=1.82, p=0.1767 respectively) (Text S7). We also
performed a series of diagnostic tests on our residuals, finding no
evidence of leverage points (Cook’s distance ,4 in all cases) or
influence points (based on leverage versus normalized squared
residual plots). After removing potential outliers based on residuals
Table 6. Associations of GDP per capita, health spending/GDP, health spending, physicians per capita, and HIV prevalence with
percentage of unmet progress toward health MDGs.
Covariate Quantity of Unmet MDG Progress
Infant Mortality Rates Child Mortality Rates Tuberculosis Mortality Rates HIV Prevalence
10% higher GDP per capita 21.16%
[22.38 to 0.055]
21.07%
[22.35 to 0.22]
22.99%
***
[23.77 to 22.21]
0.78%
[20.38 to 1.95]
1% higher Health Spending as percentage of GDP 23.08%
[29.16 to 3.01]
23.12%
[29.81 to 3.57]
24.58%
*
[28.17 to 20.99]
23.23%
[27.54 to 1.08]
$10 higher Health Spending per capita (PPP) 0.038%
[20.065 to 0.14]
0.047%
[20.079 to 0.17]
0.044%
[20.038 to 0.13]
20.085%
[20.21 to 0.036]
1 additional physician/10,000 pop. 20.12%
[20.91 to 0.66]
20.031%
[20.86 to 0.80]
1.78%
***
[1.02 to 2.54]
20.0092%
[20.93 to 0.91]
1% higher HIV Prevalence 8.47%
***
[5.57 to 11.4]
9.25%
***
[5.97 to 12.5]
5.35%
***
[4.08 to 6.62]
20.11%
[21.87 to 1.65]
Number of Countries 131 131 131 131
R
2 0.523 0.505 0.487 0.045
Notes: Results presented from four separate regression models. Constant estimated but not reported. 95% confidence intervals based on heteroskedasticity robust
standard errors in parentheses. Unmet MDG Progress is calculated in percentage terms as 1006[1–(Actual DMR/Expected DMR)]. Multiplying each coefficient by 40%
transforms the coefficient to describe the associations with the percentage change in each outcome. Progress towards reducing infant mortality rates and child
mortality rates reflects MDG 4.1 and 4.2 and modelled using a linear standard regression model. Progress towards halting or reversing tuberculosis mortality rates
reflects MDG 6.9, and modelled using a linear probability model. Progress towards halting or reversing HIV prevalence reflects MDG 6.1, and modelled using a linear
probability model. Data are from UN Millennium Development Goals Indicators 2008 edition.
*p,0.05.
**p,0.01.
***p,0.001
doi:10.1371/journal.pmed.1000241.t006
Table 7. Associations of GDP per capita, health spending/GDP, health spending, physicians per capita, HIV prevalence, and NCD
mortality rates with percentage of unmet progress toward health MDGs.
Covariate Quantity of Unmet MDG Progress
Infant Mortality Rates Child Mortality Rates Tuberculosis Mortality Rates HIV Prevalence
10% higher GDP per capita 20.17%
[21.55 to 1.21]
20.16%
[21.67 to 1.35]
21.80%
***
[22.78 to 20.82]
1.10%
[20.29 to 2.49]
1% higher Health Spending as percentage of GDP 22.23%
[28.71 to 4.25]
22.35%
[29.48 to 4.78]
23.57%
*
[26.94 to 20.19]
22.96%
[27.39 to 1.48]
$10 higher Health Spending per capita (PPP) 0.10%
[20.020 to 0.23]
0.11%
[20.050 to 0.27]
0.12%
**
[0.032 to 0.22]
20.064%
[20.19 to 0.066]
1 additional physician/10,000 pop. 20.38%
[21.25 to 0.50]
20.26%
[21.19 to 0.66]
1.47%
***
[0.75 to 2.19]
20.091%
[21.02 to 0.84]
1% higher HIV Prevalence 8.15%
***
[5.27 to 11.0]
8.95%
***
[5.66 to 12.2]
4.96%
***
[3.86 to 6.06]
20.21%
[21.96 to 1.53]
10% higher NCD Mortality Rates 6.32%
**
[2.03 to 10.6]
5.78%
*
[1.03 to 10.5]
7.56%
***
[4.73 to 10.4]
2.03%
[22.39 to 6.45]
Number of Countries 131 131 131 131
R
2 0.559 0.532 0.571 0.052
Notes: Results presented from four separate regression models. Constant estimated but not reported. 95% confidence intervals based on heteroskedasticity robust
standard errors in parentheses. Unmet MDG Progress is calculated in percentage terms as 100 [12(Actual DMR/Expected DMR)]. Multiplying each coefficient by 40%
transforms the coefficient to describe the associations with the percentage change in each outcome. Progress towards reducing infant mortality rates and child
mortality rates reflects MDG 4.1 and 4.2 and modelled using a linear standard regression model. Progress towards halting or reversing tuberculosis mortality rates
reflects MDG 6.9, and modelled using a linear probability model. Progress towards halting or reversing HIV prevalence reflects MDG 6.1, and modelled using a linear
probability model. Data are from UN Millennium Development Goals Indicators 2008 edition.
*p,0.05.
**p,0.01.
***p,0.001.
doi:10.1371/journal.pmed.1000241.t007
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(Text S5). Thus, our results were not an artefact of a few extremely
poorly performing outlier countries. We also evaluated potential
multicollinearity using variance inflation factors, finding that our
results were within accepted statistical limits (Text S5).
Discussion
Our results indicate that progress in achieving the health MDGs
for infant and child mortality and tuberculosis is associated
significantly with the burden of adult NCDs and HIV prevalence
among adults aged 15–49. The evidence emerging from these
models is consistent with a growing body of research finding that
high burdens of NCDs contribute to worse child health and poorer
tuberculosis outcomes, both as a result of biological risks from
comorbidities and as a consequence of reduced household
resources (in both human and financial terms) when faced with
multiple comorbidities (Table 1). An abundance of evidence
indicates that poor households face the greatest burdens of both
HIV and NCDs (though the diagnostic infrastructure for the latter
is focused on higher income groups), and are also the households
most affected by child mortality and tuberculosis.
We estimated that a 1% lower HIV prevalence or 10% lower
NCD risks would have an association with progress to child health
MDGs similar to a 40% or greater rise in GDP, while it would
equate to an 80% or greater rise in GDP for tuberculosis
(corresponding to about a decade of economic growth in low-
income countries). We found weaker evidence that health
spending or health infrastructure, as measured by physicians per
capita, was a major correlate of inequalities in progress by
countries towards these MDGs. While our models explained over
half of the observed inequalities among countries in progress
towards child health and tuberculosis goals, a large residual in our
measure of HIV/AIDS progress remained to be accounted for
even after evaluating economic development, health priority,
health spending, and health infrastructure as potential explana-
tions of country inequalities.
Although researchers have sought to identify barriers to
achieving progress towards MDGs in individual countries or
regions (especially sub-Saharan Africa) [42,43], this study is, to our
knowledge, the first attempt to analyse and compare the
determinants of global inequalities in progress to the health
MDGs. Inevitably, this initial analysis has several important
limitations which are relevant both to future research and to the
updates to the MDG process scheduled for 2010.
First, a comparative analysis of progress towards achievement of
health MDGs risks generating ecologic fallacies where the unit of
analysis is the country. However, our findings are consistent with a
large body of micro-level evidence indicating the importance of
NCDs among adults for the health of their dependent children and
for the control of infectious diseases (Table 1), as well as the role of
HIV in both child health and infectious disease MDGs.
Second, we cannot be certain that the associations we have
observed between HIV prevalence, NCDs, and progress towards
health MDGs are causal. One limitation is that we use cross-
sectional data to infer longitudinal relationships, making it possible
to observe a correlation cross-sectionally across countries which
does not occur longitudinally within individual country time series.
However, we have taken advantage of longitudinal data to
evaluate the rate of progress, or change, in MDG indicators. We
also need to consider two other possibilities: that either (i) poor
performance on health MDGs contributes to growing levels of
NCDs; or (ii) a third underlying factor is implicated in both poor
chronic disease outcomes and slow progress on health MDGs.
Beginning with the first mechanism, although there is now extensive
evidence from the field of life course epidemiology linking adverse
conditions in childhood to several NCDs in adulthood, the effects
are, by their nature, seen only after a lag of several decades. Also,
while some NCDs have established infectious aetiologies, such as
cervical cancer and peptic ulcers, and inflammation related to
infections may play a role in ischaemic heart disease [58,59] and
diabetes [60], these infectious agents make a relatively small
contribution to the total burden of NCDs, compared to the major
risk factors of poor diet, low physical activity, smoking, and alcohol.
Hence, the first mechanism seems implausible. It is impossible to
exclude the second in a cross-sectional analysis but we tested the
most plausible such factors (poverty, health system financing, and
health care infrastructure) and found a significant relationship
between HIV/AIDS, chronic diseases, and health MDGs indepen-
dently of these.
Third, country-wide indicators potentially mask within-country
inequalities [61]. In the future it will be important for the UN to
obtain data that can be disaggregated into different groups within
populations, as the determinants of inequalities in MDG progress
within-country may differ from the drivers of between-country
inequalities that our study has investigated.
Finally, the data available to assess MDG progress from existing
sources are limited. Although the UN database is the most
comprehensive source, many important health system perfor-
mance indicators are missing on a comparative longitudinal basis.
Time series data relating to many health MDGs in low-income
countries are presently incomplete, in particular maternal
mortality ratios and HIV prevalence. This limited the number of
health indicators we were able to study. Of the data which do exist
from poor countries, such as infant and under-5 mortality rates,
most are based on demographic projections from sentinel sites or
small surveys. Scaling up surveillance will be critical for a better
understanding of each country’s performance. If the quality of
these data is subject to error, we would expect regression to the
mean to reduce the likelihood of finding such robust and strongly
significant findings through so many tests and alternative model
specifications. Yet the findings remained robust. Also, in spite of
the important limitations of the existing data, we note that the
indicators evaluated in this analysis are the same data followed by
the UN. The ability to conduct an exercise such as this one—to
evaluate why some countries have been more successful than
others on the same targets—is a key benefit of the MDG process.
Similarly, caution is needed in using the data on NCDs from the
Global Burden of Disease study, although as we showed, our
findings are robust to exclusion of those countries where there may
be a degree of circularity because the estimates incorporate data
on childhood mortality.
These findings have implications for global health policy. The
dichotomy between adult noncommunicable mortality and the
measures included in the MDGs (communicable diseases and child
mortality) may obscure the interrelationships of illnesses affecting
those living in poor households. Programs designed to achieve the
existing health MDGs should take account of the relationships
among all those diseases that can trap households in vicious cycles
of mortality and poverty. Global health initiatives are now placing
a much greater emphasis on health systems strengthening.
However, in many cases, these are seen as a means to achieving
their specific goals, such as improving uptake of immunization
[62] or delivering antiretrovirals [63]. Our analysis, indicating
correlations among diseases and their risks, suggests that their
activities should be broadened to address the burden of other
disorders that may also, albeit less directly, impact on their ability
to achieve their goals.
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a need to investigate why and how the burden of HIV and chronic
NCDs may affect progress on child health and tuberculosis
MDGs. Further expanding data availability is crucially needed to
allow for more robust time series and panel data analysis in the
future, so that longitudinal relationships among joint epidemics
can be tracked with greater confidence.
Our findings suggest that achievement of feasible reductions in
the impact of these chronic diseases on poor households could
greatly enhance progress towards existing health MDGs. If not
adequately addressed, high rates of NCDs in low-income countries
may further impede progress towards the health MDGs.
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Background. In 2000, 189 countries adopted the United
Nations (UN) Millennium Declaration, which commits the
world to the eradication of extreme poverty by 2015. The
Declaration lists eight Millennium Development Goals
(MDGs), 21 quantifiable targets, and 60 indicators of
progress. So, for example, MDG 4 aims to reduce child
mortality (deaths). The target for this goal is to reduce the
number of children who die each year before they are five
years old (the under-five mortality rate) to two-thirds of its
1990 value by 2015. Indicators of progress toward this goal
include the under-five mortality rate and the infant mortality
rate. Because poverty and ill health are inextricably linked—
ill health limits the ability of individuals and nations to
improve their economic status, and poverty contributes to
the development of many illnesses—two other MDGs also
tackle public health issues. MDG 5 sets a target of reducing
maternal mortality by three-quarters of its 1990 level by
2015. MDG 6 aims to halt and begin to reverse the spread of
HIV/AIDS, malaria, and other major diseases such as
tuberculosis by 2015.
Why Was This Study Done? Although progress has been
madetowardachievingtheMDGs, few ifanyof the targets are
likely to bemetby2015.Worryingly, low-incomecountriesare
falling furthest behind their MDG targets. For example,
although child mortality has been declining globally, in
many poor countries there has been little or no progress.
What is the explanation for this and other inequalities in
progress toward the health MDGs? Some countries may
simply lack the financial resources needed to combat
epidemics or may allocate only a low proportion of their
gross domestic product (GDP) to health. Alternatively, money
allocated to health may not always reach the people who
need it most because of an inadequate health infrastructure.
Finally, coexisting epidemics may be hindering progress
toward the MDG health targets. Thus, the spread of HIV/
AIDS may be hindering attempts to limit the spread of
tuberculosis because HIV infection increases the risk of active
tuberculosis, and ongoing epidemics of diabetes and other
noncommunicable diseases (NCDs) may be affecting the
attainment of health MDGs by diverting scarce resources. In
this study, the researchers investigate whether any of these
possibilities is driving the inequalities in MDG progress.
What Did the Researchers Do and Find? The researchers
calculated how far 227 countries were from their MDG
targets for HIV, tuberculosis, and infant and child mortality in
2005 using information collected by the UN. They then used
statistical methods to study the relationship between this
distance and economic development (GDP per person),
health spending as a proportion of GDP (health priority),
actual health system expenditures, health infrastructure, HIV
burden, and NCD burden in each country. Economic
development, health priority, health spending, and health
infrastructure explained no more than one-fifth of the
inequalities in progress toward health MDGs. By contrast,
the HIV and NCD burdens explained more than half of
inequalities in child mortality progress and were strongly
associated with unequal progress toward tuberculosis goals.
Furthermore, the researchers calculated that a 1% reduction
in the number of people infected with HIV or a 10%
reduction in rate of deaths from NCDs in a population would
have a similar impact on progress toward the tuberculosis
MDG target as a rise in GDP corresponding to at least a
decade of growth in low-income countries.
What Do These Findings Mean? These findings are
limited by the quality of the available data on health
indicators in low-income countries and, because the
researchers used country-wide data, their findings only
reveal possible drivers of inequalities in progress toward
MDGs in whole countries and may mask drivers of within-
country inequalities. Nevertheless, as one of the first
attempts to analyze the determinants of global inequalities
in progress toward the health MDGs, these findings have
important implications for global health policy. Most
importantly, the finding that unequal progress is related to
the burdens of HIV and NCDs in populations suggests that
programs designed to achieve health MDGs must consider
all the diseases and factors that can trap households in
vicious cycles of illness and poverty, especially since the
achievement of feasible reductions in NCDs in low-income
countries could greatly enhance progress towards health
MDGs.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000241.
N The United Nations Millennium Development Goals website
provides detailed information about the Millennium Decla-
ration, the MDGs, their targets and their indicators
N The Millennium Development Goals Report 2009 and its
progresschart provide anup-to-date assessmentofprogress
towards the MDGs
N The World Health Organization provides information about
poverty and health and health and development
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